The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Plasma tranylcypromine: relationship to pharmacokinetic variables and clinical antidepressant actions.
A G Mallinger; J M Himmelhoch; M E Thase; D J Edwards; S Knopf (Profiled Author: Alan Mallinger)
Department of Psychiatry, School of Medicine, University of Pittsburgh, Pennsylvania.
Journal of clinical psychopharmacology 1990;10(3):176-83.
Because the clinical actions of psychotherapeutic agents can be influenced by their pharmacokinetics, we investigated plasma tranylcypromine in relation to treatment outcome in 26 patients with bipolar depression. After oral administration of a tranylcypromine dose, plasma drug levels were measured hourly from 5-8 hours (N = 16) or 0-8 hours (N = 10) postdose, and pharmacokinetic parameters were calculated. Depressive symptoms were rated using the Hamilton Rating Scale for Depression (HAM-D), and subjects were categorized as responders, partial responders, or nonresponders, based on end-pair ratings. Twelve subjects were responders, seven were partial responders, and seven were nonresponders (mean scores = 3.2, 13.1, and 24.9, respectively); pretreatment HAM-D scores did not differ among the three groups. Tranylcypromine elimination (t1/2) was unrelated to clinical outcome. However, plasma tranylcypromine measured 5 hours postdose (5hTCP) was correlated with the end-pair HAM-D scores (r = 0.48, p less than 0.015) and was significantly higher in nonresponders than in responders (ANOVA, F = 4.7, p less than 0.02; Newman-Keuls test, p less than 0.05). For subjects who were studied from 0-8 hours postdose, the time to peak absorption (Tpeak), the area under the plasma tranylcypromine-versus-time curve, and the volume of distribution (Vd) were determined. Two subjects having delayed (3-4 hours) Tpeak also manifested elevated mean 5hTCP (63.9 vs. 34.1 ng/ml).(ABSTRACT TRUNCATED AT 250 WORDS)
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
A G Mallinger; D J Edwards; J M Himmelhoch; S Knopf; J EhlerClinical pharmacology and therapeutics 1986;40(4):444-50.
J R DePaulo; S G Simpson; J O Gayle; S E FolsteinJournal of affective disorders 1990;19(4):259-64.
Sarah Kayser; Bettina Bewernick; Nikolai Axmacher; Thomas E SchlaepferThe journal of ECT 2009;25(2):137-40.
Appears in this Publication
Author of this Publication